Title : FASN inhibition targets multiple drivers of NASH by reducing steatosis, inflammation and fibrosis in preclinical models - O'Farrell_2022_Sci.Rep_12_15661 |
Author(s) : O'Farrell M , Duke G , Crowley R , Buckley D , Martins EB , Bhattacharya D , Friedman SL , Kemble G |
Ref : Sci Rep , 12 :15661 , 2022 |
Abstract : O'Farrell_2022_Sci.Rep_12_15661 |
ESTHER : O'Farrell_2022_Sci.Rep_12_15661 |
PubMedSearch : O'Farrell_2022_Sci.Rep_12_15661 |
PubMedID: 36123383 |
O'Farrell M, Duke G, Crowley R, Buckley D, Martins EB, Bhattacharya D, Friedman SL, Kemble G (2022)
FASN inhibition targets multiple drivers of NASH by reducing steatosis, inflammation and fibrosis in preclinical models
Sci Rep
12 :15661
O'Farrell M, Duke G, Crowley R, Buckley D, Martins EB, Bhattacharya D, Friedman SL, Kemble G (2022)
Sci Rep
12 :15661